Global Vaccine Safety and the FDA

A recent announcement from the Food and Drug Administration (FDA) raises some interesting questions about the ways in which we track vaccine safety. The FDA’s Center for Biologics Evaluation and Research has declared its intention to launch a new program titled the “Global Regulatory Utilization of Vaccine Safety and Surveillance (GRUVSS) initiative.” The aim of … Continue reading

Gates Foundation Invests in Pharma: Conflict of Interest?

In March of this year, the Bill & Melinda Gates Foundation invested $10 million in Liquidia Technologies, a biotechnology company focused on vaccine development. According to Jeff Raikes, the CEO of the Gates Foundation, this is a way to “tap into the private sector … [to] add to the work we are doing and leverage … Continue reading